Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others References World Health Organization
For oral semaglutide (Rybelsus), the FDA prescribing information specifically notes increased thyroxine exposure when co-administered with levothyroxine
Yes, patients with well-controlled Hashimoto's thyroiditis on stable levothyroxine therapy can generally use tirzepatide when indicated for type 2 diabetes or obesity management
Fluctuating vision that varies throughout the day, especially during dose adjustments Difficulty with your usual glasses or contact lens prescription Mild light sensitivity that resolves over several weeks Dry eye symptoms that artificial tears can help manage If you need new glasses, wait until your blood sugar has been stable for six to eight weeks
